Journal article icon

Journal article

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

Abstract:

BACKGROUND: The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the same trial. METHODS: We administered RTS,S/AS01 or a comparator vaccine to 6537 infants who were 6 to 12 weeks of age at the time of the first vaccination in conjunction with Expanded Program on Immunization (EPI) vaccines in a three-dose monthly sc...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1056/nejmoa1208394

Authors


Agnandji, ST More by this author
Fernandes, JF More by this author
Abossolo, BP More by this author
Methogo, BG More by this author
Expand authors...
Journal:
The New England journal of medicine
Volume:
367
Issue:
24
Pages:
2284-2295
Publication date:
2012-12-05
DOI:
EISSN:
1533-4406
ISSN:
0028-4793
URN:
uuid:91882ef5-c5cc-4b7c-bf09-935007464502
Source identifiers:
367768
Local pid:
pubs:367768

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP